nirsevimab
FDA Approves Enflonsia, Second RSV Antibody for Infants
The FDA has approved the second monoclonal antibody for the prevention of RSV in neonates and infants, ...
JUNE 10, 2025
Infant RSV Hospitalization Rates Dropped Significantly After Antibody, Vaccine Prevention Introduced
RSV-associated hospitalization in infants fell sharply during the first virus season after the introduction of ...
JUNE 5, 2025
Load more